CATIE-Alzheimer's Disease Trial
Public ClinicalTrials.gov record NCT00015548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The CATIE Alzheimer's Disease Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project. The study is for people with Alzheimer's disease who are having trouble with their thinking or behavior. In particular, this study is trying to find out the best treatment for people who have hallucinations (seeing or hearing things that aren't there), delusions (false beliefs), or agitation. The design of the trial helps to increase the chance that participants in the study receive a medication that helps them. The study uses three medications known as atypical antipsychotics (olanzapine, quetiapine, risperidone), which are the newest medications that are currently available for treating these problems. Participants may also receive an antidepressant (citalopram). The trial lasts for 36 weeks. Participants are given a thorough evaluation at no cost to ensure that this study is appropriate. In addition, the caregiver, family member, or friend who comes with the participant will be offered an educational program about Alzheimer's disease.
Study identification
- NCT ID
- NCT00015548
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2004 (Type not available)
- Last update posted
- Jun 17, 2015
2001 – 2004
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tuscaloosa VA Medical Center | Tuscaloosa | Alabama | 35404 | — |
| University of California, Irvine Medical Center | Irvine | California | 92697 | — |
| University of Southern California Dept of Psychiatry& Behavioral Sciences | Los Angeles | California | 90033 | — |
| University of California, Los Angeles, VA Medical Center | Los Angeles | California | 90073 | — |
| University of California-San Diego, VA Medical Center | San Diego | California | 92161 | — |
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Mental Health Advocates, Inc. | Boca Raton | Florida | 33432 | — |
| Berma Research Group | Hialeah | Florida | 33016 | — |
| University of South Florida Suncoast Gerontology Center | Tampa | Florida | 33617 | — |
| Palm Beach Neurology/Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Emory University - Wesley Woods Health Center | Atlanta | Georgia | 30329 | — |
| University of Hawaii | Honolulu | Hawaii | 96813 | — |
| Northwestern University Medical School | Chicago | Illinois | 60611 | — |
| Southern Illinois School of Medicine | Springfield | Illinois | 62702 | — |
| University of Iowa College of Medicine | Iowa City | Iowa | 52242 | — |
| Louisiana State University Health Sciences Center | Shreveport | Louisiana | 71103 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Millennium Psychiatric Associates | St Louis | Missouri | 63044 | — |
| University of Medicine and Dentistry of New Jersey | Piscataway | New Jersey | 08855-1382 | — |
| University of Medicine and Dentistry of New Jersey-Stratford | Stratford | New Jersey | 08084 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Columbia University | New York | New York | 10032 | — |
| Global Research and Consulting | Olean | New York | 14760 | — |
| Monroe Community Hospital | Rochester | New York | 14620 | — |
| Staten Island University Hospital | Staten Island | New York | 10305 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| University Hospital Health Systems-Laurelwood Hospital | Willoughby | Ohio | 44904 | — |
| VA Medical Center | Coatesville | Pennsylvania | 19320 | — |
| Mental Illness Research Education and Clinical Center | Philadelphia | Pennsylvania | 19104 | — |
| Medical University of South Carolina | North Charleston | South Carolina | 29406 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235-9070 | — |
| Southwestern Vermont Medical Center- The Memory Clinic | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00015548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2015 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00015548 live on ClinicalTrials.gov.